This was on Westpac.
Mesoblast has successfully met the pre-specified primary endpoint, prospectively agreed with FDA, of a single-arm Phase 3 trial in 54 children with SR-aGvHD. While the Oncologic Drugs Advisory Committee of FDA in August 2020 voted 9:1 in favor of remestemcel-L’s efficacy in a pediatric patient population, in September 2020 FDA recommended further steps be undertaken to obtain approval. The BLA resubmission of January 2023 included long-term follow-up data from the Phase 3 trial by the Center for International Blood and Marrow Transplant Research (CIBMTR) showing 50% survival through more than 4 years of follow-up for remestemcel-L treated patients in the Phase 3 trial for whom less than 20% survival at two years was expected based on disease severity. The resubmission also included a post-hoc propensity matched study showing 6 month survival was 67% with remestemcel-L vs 10% with other unapproved therapies in highest-risk patients as identified using the Mount Sinai Acute GVHD International Consortium (MAGIC). These pediatric data provide further support for use of remestemcel- L in the proposed study in high-risk adults with SR-aGVHD.
- Forums
- ASX - By Stock
- MSB
- Ann: Trading Halt
Ann: Trading Halt, page-1143
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32370 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 60258 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32370 | 0.925 |
9 | 98847 | 0.920 |
20 | 130822 | 0.915 |
15 | 194562 | 0.910 |
7 | 97027 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 60258 | 5 |
0.935 | 28119 | 2 |
0.940 | 20797 | 3 |
0.945 | 59774 | 3 |
0.950 | 26619 | 3 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |